BCL2 and glioblastoma: Overexpression of miRNA-21 has also been associated with glioblastoma resistance to temozolomide, the standard first-line treatment, by impacting the balance between the pro-apoptotic Bax protein and the anti-apoptotic Bcl-2, as well as by influencing Caspase 3 activity [17].